vs
Side-by-side financial comparison of BrightSpire Capital, Inc. (BRSP) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
BrightSpire Capital, Inc. is the larger business by last-quarter revenue ($83.2M vs $75.5M, roughly 1.1× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -0.4%). BrightSpire Capital, Inc. produced more free cash flow last quarter ($55.1M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -6.8%).
Oakley Capital Investments, is a large British investment trust focused on investments in mid-market companies in the business services, consumer, education and technology sectors. The company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
BRSP vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.2M | $75.5M |
| Net Profit | $-14.4M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | — | 22.7% |
| Net Margin | -17.3% | — |
| Revenue YoY | -0.4% | 27.7% |
| Net Profit YoY | 27.3% | — |
| EPS (diluted) | $-0.11 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $83.2M | $75.5M | ||
| Q3 25 | $83.9M | $54.5M | ||
| Q2 25 | $85.9M | $52.4M | ||
| Q1 25 | $77.6M | $46.0M | ||
| Q4 24 | $83.5M | $59.1M | ||
| Q3 24 | $88.2M | $80.5M | ||
| Q2 24 | $91.4M | $47.1M | ||
| Q1 24 | $95.8M | $43.8M |
| Q4 25 | $-14.4M | — | ||
| Q3 25 | $984.0K | $8.8M | ||
| Q2 25 | $-23.1M | $5.9M | ||
| Q1 25 | $5.3M | $3.0M | ||
| Q4 24 | $-19.7M | — | ||
| Q3 24 | $12.7M | $20.3M | ||
| Q2 24 | $-67.9M | $-4.5M | ||
| Q1 24 | $-57.1M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | — | 22.7% | ||
| Q3 25 | -1.7% | 17.6% | ||
| Q2 25 | -54.5% | 12.7% | ||
| Q1 25 | 5.1% | 8.7% | ||
| Q4 24 | -24.9% | 22.6% | ||
| Q3 24 | 13.2% | 27.4% | ||
| Q2 24 | -74.9% | -4.6% | ||
| Q1 24 | -59.4% | -5.3% |
| Q4 25 | -17.3% | — | ||
| Q3 25 | 1.2% | 16.2% | ||
| Q2 25 | -26.9% | 11.2% | ||
| Q1 25 | 6.9% | 6.5% | ||
| Q4 24 | -23.7% | — | ||
| Q3 24 | 14.4% | 25.2% | ||
| Q2 24 | -74.2% | -9.6% | ||
| Q1 24 | -59.6% | -11.0% |
| Q4 25 | $-0.11 | $0.26 | ||
| Q3 25 | $0.00 | $0.17 | ||
| Q2 25 | $-0.19 | $0.12 | ||
| Q1 25 | $0.04 | $0.06 | ||
| Q4 24 | $-0.16 | $0.40 | ||
| Q3 24 | $0.09 | $0.41 | ||
| Q2 24 | $-0.53 | $-0.09 | ||
| Q1 24 | $-0.45 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $66.8M | $97.5M |
| Total DebtLower is stronger | $2.5B | $22.7M |
| Stockholders' EquityBook value | $938.4M | $130.3M |
| Total Assets | $3.6B | $216.3M |
| Debt / EquityLower = less leverage | 2.63× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $66.8M | $97.5M | ||
| Q3 25 | $113.4M | $94.4M | ||
| Q2 25 | $154.3M | $96.0M | ||
| Q1 25 | $200.9M | $93.2M | ||
| Q4 24 | $302.2M | $101.0M | ||
| Q3 24 | $263.8M | $96.7M | ||
| Q2 24 | $203.3M | $96.8M | ||
| Q1 24 | $221.5M | $107.2M |
| Q4 25 | $2.5B | $22.7M | ||
| Q3 25 | $2.2B | $34.0M | ||
| Q2 25 | $2.3B | $45.3M | ||
| Q1 25 | $2.3B | $56.7M | ||
| Q4 24 | $2.5B | $68.0M | ||
| Q3 24 | $2.6B | $79.3M | ||
| Q2 24 | $2.5B | $90.7M | ||
| Q1 24 | $2.6B | $102.0M |
| Q4 25 | $938.4M | $130.3M | ||
| Q3 25 | $976.4M | $115.3M | ||
| Q2 25 | $994.4M | $104.7M | ||
| Q1 25 | $1.0B | $97.1M | ||
| Q4 24 | $1.0B | $92.1M | ||
| Q3 24 | $1.1B | $71.1M | ||
| Q2 24 | $1.1B | $48.5M | ||
| Q1 24 | $1.2B | $51.0M |
| Q4 25 | $3.6B | $216.3M | ||
| Q3 25 | $3.3B | $202.9M | ||
| Q2 25 | $3.4B | $194.9M | ||
| Q1 25 | $3.6B | $196.2M | ||
| Q4 24 | $3.7B | $213.3M | ||
| Q3 24 | $3.8B | $220.7M | ||
| Q2 24 | $3.8B | $205.0M | ||
| Q1 24 | $3.9B | $214.1M |
| Q4 25 | 2.63× | 0.17× | ||
| Q3 25 | 2.22× | 0.30× | ||
| Q2 25 | 2.27× | 0.43× | ||
| Q1 25 | 2.27× | 0.58× | ||
| Q4 24 | 2.38× | 0.74× | ||
| Q3 24 | 2.36× | 1.12× | ||
| Q2 24 | 2.28× | 1.87× | ||
| Q1 24 | 2.17× | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $73.0M | $14.4M |
| Free Cash FlowOCF − Capex | $55.1M | $14.4M |
| FCF MarginFCF / Revenue | 66.2% | 19.1% |
| Capex IntensityCapex / Revenue | 21.6% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $102.0M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $73.0M | $14.4M | ||
| Q3 25 | $29.9M | $9.7M | ||
| Q2 25 | $17.4M | $14.1M | ||
| Q1 25 | $10.5M | $3.6M | ||
| Q4 24 | $103.4M | $15.6M | ||
| Q3 24 | $31.3M | $11.0M | ||
| Q2 24 | $22.9M | $1.0M | ||
| Q1 24 | $24.6M | $11.2M |
| Q4 25 | $55.1M | $14.4M | ||
| Q3 25 | $27.4M | $9.7M | ||
| Q2 25 | $11.6M | $14.1M | ||
| Q1 25 | $8.0M | $3.6M | ||
| Q4 24 | $97.3M | $15.6M | ||
| Q3 24 | $28.3M | $11.0M | ||
| Q2 24 | $22.7M | $1.0M | ||
| Q1 24 | $22.2M | — |
| Q4 25 | 66.2% | 19.1% | ||
| Q3 25 | 32.7% | 17.7% | ||
| Q2 25 | 13.4% | 26.8% | ||
| Q1 25 | 10.3% | 7.7% | ||
| Q4 24 | 116.6% | 26.4% | ||
| Q3 24 | 32.1% | 13.7% | ||
| Q2 24 | 24.9% | 2.1% | ||
| Q1 24 | 23.2% | — |
| Q4 25 | 21.6% | 0.0% | ||
| Q3 25 | 2.9% | 0.0% | ||
| Q2 25 | 6.8% | 0.0% | ||
| Q1 25 | 3.2% | 0.1% | ||
| Q4 24 | 7.3% | 0.0% | ||
| Q3 24 | 3.4% | 0.0% | ||
| Q2 24 | 0.1% | 0.0% | ||
| Q1 24 | 2.5% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | 30.36× | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | 1.97× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.46× | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
